Investment Report for October-November 2025: My Results and Market Analysis
Reading time: ~8 minutes
๐ Key Performance Metrics (October-November)
Total Portfolio Return: +11.8% (over 2 months)
Return vs S&P 500: +6.5%
YTD Return: 57.55%
Total Portfolio Value: $19,525.79
Realized Profit/Loss: +$7,119.38
Quick Overview
Two months without reports – and there’s a reason for that! (September report) I spent October on vacation in Costa Rica ๐ด, so I skipped the October report. But the portfolio didn’t rest and went through a real rollercoaster: October was positive, November brought a significant correction, but by month’s end, almost everything recovered. Bottom line: +12% over two months.
Key Events of the Period:
- Continued tech stock rally (October)
- November correction – portfolio lost 8-10% at the peak of the decline
- Rapid recovery – by month’s end, almost back to previous levels
- Fear & Greed Index remains at low levels – market in fear mode
- CLS reached incredible +423% since initial investment
- New position HOWL appeared (unsuccessful)
- Some speculative positions showed weakness
๐ฏ Top Positions of the Period
๐ข Absolute Growth Leaders
1. Celestica Inc ($CLS) – ๐ PORTFOLIO CHAMPION
- End of September: $3,424.70 CAD (+273%)
- End of November: $4,801.10 CAD (+423%)
- Change over 2 months: +40.2%
- My position: 24.35% of RRSP portfolio
- Comment: Absolute star! Growth since initial investment exceeded 420%! When I started investing, I couldnโt even imagine something like this.๐
2. AMD (Advanced Micro Devices) – +34.2%
- End of September: $964.38 USD (+62.17%)
- End of November: $1,307.16 USD (+119.82%)
- Change over 2 months: +35.5%
- My position: 6.63% of RRSP portfolio
- Comment: Semiconductors continue strong growth
3. AppLovin Corp ($APP) – +5.8%
- End of September: $564.53 USD (+87.69%)
- End of November: $474.20 USD (+57.66%)
- Change over 2 months: -16.0%
- My position: 12.90% of TFSA portfolio
- Comment: Correction after S&P 500 inclusion, but still solidly in the green
๐ข Other Strong Performers
4. AEM (Agnico Eagle Mines) – +23.5%
- Growth from $944.44 CAD to $982.28 CAD
- All time return: +68.95%
5. TSM (Taiwan Semiconductor) – RRSP – +5.1%
- Growth from $836.20 USD to $879.45 USD
- All time return: +62.20%
6. INVZ (Innoviz Technologies) – -34.0%
- Drop from $447.50 USD to $295.26 USD
- All time return: +16.55% (was +76.64%)
- Comment: Significant correction of speculative position
๐ด Period’s Underperformers
1. HOWL (Werewolf Therapeutics) – -51.49% โ ๏ธโ ๏ธ
- New position: 22 shares at $0.9991 USD
- All time return: -51.49%
- Status: Worst investment in portfolio
- Comment: Biotech speculation didn’t pan out, sharp decline
2. GSY (GoEasy Limited) – -8.84%
- Drop from $424.13 CAD to $345.63 CAD
- Loss of $78.50 CAD
3. BBAI (BigBear.ai Holdings) – -27.52%
- Drop from $70.63 USD to $68.99 USD
- Continues struggling after August crash
4. DV (DoubleVerify Holdings) – -29.14%
- Continues decline (was -21.92%)
- Weakest position among more stable companies
๐ผ New Investments and Portfolio Changes
New Purchases
$HOWL (Werewolf Therapeutics Inc) – 22 shares at ~$0.9991 USD
- Investment thesis: Biotechnology company, speculative position
- Result: -51.49% ๐
- Lesson: High risk = high losses. Biotech requires much more thorough analysis
Sales
No sales over the two months.
Position Adjustments
- DFLI: Remains in portfolio, awaiting developments
- Most positions remained unchanged
๐ Portfolio Sector Allocation
๐ป Technology & Semiconductors: ~48% (โ from 45%)
๐ Healthcare: ~16% (โ from 18%)
โ๏ธ Mining & Resources: ~11% (โ from 12%)
๐๏ธ Industrials/Construction: ~10% (โ from 9%)
๐ ETFs & Indices: ~8% (โ from 9%)
๐ฐ Financials: ~7% (โ from 8%)
Changes: Technology percentage increased due to strong growth of AMD and CLS.
๐ What Influenced the Market in October-November
Macroeconomic Factors
- Continuation of rate cut cycle – markets responded positively to accommodative monetary policy
- November correction – uncertainty about the pace of rate cuts triggered selloffs
- Fear & Greed Index – in the “Fear” zone, which historically signals buying opportunities
- Q3 earnings season – tech companies showed strong results
- Geopolitical tensions – some impact on volatility
November Market Dynamics
What Happened:
- Mid-November brought a sharp correction ๐
- My portfolio lost 8-10% at the peak of the decline
- Tech sector suffered the most
- By month’s end – almost complete recovery ๐
Why It Matters:
- Reminder of market volatility
- Portfolio stress test
- Opportunity to buy at lower prices (if cash available)
Corporate News
- Celestica continued to impress – each quarter exceeds expectations
- AMD benefited from AI boom – demand for AI chips supports growth
- AppLovin correction – natural correction after sharp rise
- Biotech under pressure – HOWL and other small biotech companies suffering
๐ Lessons from Two Months
What Worked Well โ
1. Concentration in quality companies
- CLS and AMD continue to demonstrate strength
- Large positions in the right companies = foundation of success
2. Patience with best positions
- Holding CLS since February – result +423%
- Didn’t sell through waves of volatility
- Didn’t panic during November correction – and it paid off โ
3. Diversification between accounts
- TFSA account more speculative
- RRSP more stable and conservative
4. Didn’t sell during the drop
- November showed that holding positions matters more than emotions
- Those who sold at the bottom – missed the recovery
What Can Be Improved ๐
1. HOWL – biggest mistake of the period
- -51.49% immediately after purchase
- Insufficient research before investment
- Biotech requires significantly more expertise
2. Too many positions
- 28 different stocks/ETFs – hard to follow all
- Better to have 15-20 quality positions than 28 of varying quality
3. Speculative positions
- INVZ, BBAI, SPCB, SRTS, HOWL – all showing weakness
- May need to reconsider approach to speculations
Key Takeaways ๐ก
1. Quality matters more than quantity
- 10% in CLS generated more profit than 5 small speculations combined
2. Not all sectors are equal
- Tech/AI = strong trend
- Biotech = requires deep expertise
3. Rebalancing necessary
- CLS already 24% of RRSP portfolio – perhaps too much?
- Need to think about taking some profits
4. Volatility is normal
- November correction of -8-10% was scary in the moment
- But recovery came quickly
- Fear & Greed Index in fear zone = opportunities for patient investors
5. Emotions are the biggest enemy
- During the drop, wanted to sell
- But logic prevailed over emotions
- Result: almost complete recovery
๐ฎ Plans for December
Critical Decisions ๐ฏ
1. What to do with HOWL?
- Loss of 50%+ immediately
- Options: sell and realize loss, or wait for recovery?
- Decision: Will monitor for another month
2. CLS – take profits?
- +423% – phenomenal result
- Position already 24% of portfolio
- Decision: Will consider selling 30-40% of position for rebalancing
3. Speculative positions
- Continue holding BBAI, SRTS, SPCB?
- All showing weakness
What I’m Watching ๐
Energy Sector:
- AI needs energy – looking for interesting companies
- Possible candidates: nuclear energy, renewables
December Reports:
- Monitoring reports from main positions
- Tax loss selling season – may see good prices
Strategic Goals ๐ฏ
1. Portfolio Rebalancing
- Reduce number of positions from 28 to 20
- Sell weakest speculative positions
- Increase stakes in quality companies
2. Add New Positions
- Energy sector (1-2 companies)
- Possibly add infrastructure plays
3. Investment Regularity
- Return to monthly contributions
- Even small amounts matter
๐ก Dividends and Passive Income
Dividends received for October-November: ~CAD $37 (didn’t track exact monthly breakdown)
Total dividends since start of investing: CAD $128.85
Of which last 3 months: CAD $43.80
Dividend income is growing with the portfolio. From small CAD $6.95 in September to approximately CAD $18-19 per month now.
Dividend positions in portfolio:
- RF (Regions Financial Corp) – quarterly
- JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) – monthly
- UNH (UnitedHealth Group) – quarterly
๐ Year-to-Date Statistics
Overall Metrics:
- YTD Return: +58.96%
- Best Month: September 2025 (+11.6%)
- Second Best Month: October-November (+11.8% over 2 months)
- Number of Trades: 3 (DFLI, HOWL, + one more)
- Total Number of Positions: 29 stocks/ETFs
Best YTD Investments:
- CLS: +423.00% ๐
- AMD: +119.82% ๐ฅ
- TSM (TFSA): +60.04% ๐ฅ
- AEM: +68.95%
- APP: +57.66%
Worst YTD Investments:
- HOWL: -51.49% ๐
- DV: -29.14%
- BBAI: -27.52%
- SRTS: -27.79%
- SPCB: -24.02%
๐ Detailed Portfolio Analysis
TFSA Portfolio (Tax-Free Savings Account)
Value: ~$3,670 USD
Main Positions:
- APP: $474.20 USD (+57.66%)
- INVZ: $295.26 USD (+16.55%) – significant correction
- IONQ: $121.08 USD (+20.70%)
- AMZN: $233.11 USD (+5.19%)
- META: $179.97 USD (-9.86%)
Character: More aggressive, tech-focused
RRSP Portfolio (Registered Retirement Savings Plan)
Value: ~$16,050 CAD + USD
Main Positions:
- CLS: $4,801.10 CAD (+423.00%) – dominant position
- AMD: $1,307.16 USD (+119.82%)
- DOL: $1,602.40 CAD (+26.76%)
- AEM: $982.28 CAD (+68.95%)
- TSM: $879.45 USD (+62.20%)
Character: More stable, diversified
โ Discussion Questions
Interested to hear your thoughts:
- What would you do with HOWL? Would you sell immediately at -50% or wait for recovery?
- CLS already +423% – isn’t it time to take profits? What are your rules for selling winners?
- How many positions are optimal for a private investor? 15? 20? 30?
- Energy sector – which companies are you considering in the context of AI boom?
Write in the comments, I’ll be happy to discuss! ๐ฌ
๐ Summary
October and November became a real test for the portfolio and my nerves. YTD return reached nearly 59%, significantly exceeding market indices. So far, my portfolio strategy is working well.
November correction was an important lesson: a drop of 8-10% looked scary, but holding positions proved to be the right decision. By month’s end, the portfolio almost fully recovered.
Fear & Greed Index is still in the fear zone, which historically means good opportunities for long-term investors. The market is scared, but fundamental indicators of quality companies (CLS, AMD, TSM) remain strong.
The key to success remains unchanged – concentration in quality tech companies plus patience during volatility. At the same time, new challenges emerged: HOWL showed that not all investments are successful, and some speculative positions need reassessment.
December will be a month of important decisions regarding rebalancing and portfolio optimization.
Main lesson: quality matters more than quantity, and patience matters more than emotions. Better to have 15-20 well-researched positions and hold them through corrections than to sell in panic. I tried to pick the best Canadian stocks, but so far not all of them have performed well.
Thank you for reading my reports! See you in December’s report! ๐๐
Disclaimer: This post is not investment advice. All investments carry risks, and past performance does not guarantee future results. Always conduct your own research or consult with a financial advisor before making investment decisions.
#investing #stocks #stockmarket #portfolio #Celestica #AMD #AppLovin #AI #techstocks #TFSA #RRSP #dividends #finance #november2025 #october2025 #investmentreport #semiconductors #passiveincome #financialliteracy #marketcorrection #fearandgreed
Subscribe for monthly reports and investment insights!
